Currently out of the existing stock ratings of Yi Chen, 655 are a BUY (93.57%), 45 are a HOLD (6.43%).

Yi Chen

Work Performance Price Targets & Ratings Chart

Analyst Yi Chen, carries an average stock price target met ratio of 45.46% that have a potential upside of 58.91% achieved within 282 days. Previously, Yi Chen worked at AEGIS.

Yi Chen’s has documented 1,332 price targets and ratings displayed on 72 stocks. The coverage was on Healthcare, Consumer Cyclical, Industrials, Technology, Consumer Defensive, Energy sectors.

Most recent stock forecast was given on TEM, Tempus AI, Common Stock.

Wall Street Analyst Yi Chen

Analyst best performing recommendations are on BEAT (HEARTBEAM).
The best stock recommendation documented was for BEAT (HEARTBEAM) at 12/8/2025. The price target of $2.5 was fulfilled within 7 days with a profit of $1.7 (212.5%) receiving and performance score of 303.57.

Average potential price target upside

of $12727.12 (77.78%) on APDN (APPLIED DNA SCIENCES).
of $8394.82 (54.62%) on FWBI (FIRST WAVE BIOPHARMA).
of $34.96 (126.34%) on TCOM (TRIP.COM GROUP LTD ADR).

ASLN Aslan Pharmaceuticals Ltd ADR AZRX AzurRx BioPharma IDXG Interpace Biosciences APDN Applied DNA Sciences CODX Co-Diagnostics HTGM HTG Molecular Diagnostics KALA Kala Pharmaceuticals OCDX Ortho Clinical Diagnostics Holdings plc OCUL Ocular Therapeutix RNLX Renalytix AI EYPT Eyepoint Pharmaceuticals KPRX Kiora Pharmaceuticals MOTS Motus GI Holdings PRPH ProPhase Labs VACC VIVO Meridian Bioscience BLCO Bausch + Lomb Corp SRTS Sensus Healthcare ZYXI Zynex VERU Veru FWBI First Wave BioPharma ALIM Alimera Sciences ANIX Anixa Biosciences BLTE Belite Bio ADR CLSD Clearside Biomedical CNTG Centogene B V ICCM Icecure Medical MYNZ Mainz Biomed BV NMRD Nemaura Medical OPK Opko Health ANGO AngioDynamics DRTS Alpha Tau Medical Ltd LFMD LifeMD OPGN OpGen AADI Aadi Bioscience BPTH Bio Path Holdings CDNA Caredx CELC Celcuity LLC CHEK Check Cap Ltd MITO Stealth BioTherapeutics Corp XRAY Dentsply Sirona EYEN Eyenovia RGNX Regenxbio GLSI Greenwich Lifesciences OBIO Orchestra BioMed Holdings OCS Oculis Holding AG Ordinary shares SMTI Sanara Medtech TRML Tourmaline Bio BLFS BioLife Solutions BNGO Bionano Genomics CTRP Trip.com Group ELDN Eledon Pharmaceuticals HROW Harrow Health LPCN Lipocine TCOM Trip.com Group Ltd ADR GNPX Genprex AXGN Axogen EDSA Edesa Biotech NPCE Neuropace AL Air Lease AS Amer Sports AZ A2Z Smart Technologies Corp BEAT Heartbeam CLS Celestica EYE National Vision Holdings EYEG AB Corporate Bond ETF MO Altria Group STML Stemline Therapeutics TEM Tempus AI, Common Stock VAC Marriot Vacations Worldwide VNRX Volitionrx Ltd BP BP PLC ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Yi Chen (HCWAINWRIGHT)

Buy

2 years 4 months 11 days ago
(03-May-2024)

2/5 (40%)

$13.4 (372.22%)

248

Please subscribe to see extended stock data

Edward Tenthoff (PIPER SANDLER)

Buy

$15

2 years 6 months 1 days ago
(13-Mar-2024)

1/9 (11.11%)

$11.06 (280.71%)

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Yi Chen most bullish on?

Potential upside of $71.21 has been obtained for BLTE (BELITE BIO ADR)

Which stock is Yi Chen most reserved on?

Potential downside of -$4.26 has been obtained for CDNA (CAREDX)